Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RIT1 oncoproteins escape LZTR1-mediated proteolysis
Pau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Science (2019) Vol. 363, Iss. 6432, pp. 1226-1230
Open Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts
Lin Jiang, Jingjing Zheng, Johnny S. H. Kwan, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 16, pp. e96-e96
Open Access | Times Cited: 31
Cross-species analysis of LZTR1 loss-of-function mutants demonstrates dependency to RIT1 orthologs
Antonio Cuevas-Navarro, Laura Rodríguez-Muñoz, Joaquím Grego‐Bessa, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 16
The RAS-Regulated RAF-MEK1/2-ERK1/2 Protein Kinase Pathway: The Path Most Traveled in RASopathies
Rafał Dutkiewicz, Hayley J. Sharpe, Simon J. Cook
(2024), pp. 397-425
Closed Access | Times Cited: 3
Discovering How Heme Controls Genome Function Through Heme-omics
Ruiqi Liao, Ye Zheng, Xin Liu, et al.
Cell Reports (2020) Vol. 31, Iss. 13, pp. 107832-107832
Open Access | Times Cited: 27
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
Alisa Damnernsawad, Daniel Bottomly, Stephen E. Kurtz, et al.
Haematologica (2020) Vol. 107, Iss. 1, pp. 77-85
Open Access | Times Cited: 26
Cracking the Monoubiquitin Code of Genetic Diseases
Raj Nayan Sewduth, Maria Francesca Baietti, Anna Sablina
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3036-3036
Open Access | Times Cited: 25
Cullin 3 and Its Role in Tumorigenesis
Ruey‐Hwa Chen
Advances in experimental medicine and biology (2020), pp. 187-210
Closed Access | Times Cited: 24
The RAS GTPase RIT1 compromises mitotic fidelity through spindle assembly checkpoint suppression
Antonio Cuevas-Navarro, Richard Van, Alice Cheng, et al.
Current Biology (2021) Vol. 31, Iss. 17, pp. 3915-3924.e9
Open Access | Times Cited: 22
LZTR1: A promising adaptor of the CUL3 family (Review)
Hui Zhang, Xinyi Cao, Jian Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
Liang-Zhan Sun, Shaoyan Xi, Zhengdong Zhou, et al.
Oncogene (2021) Vol. 41, Iss. 5, pp. 732-744
Closed Access | Times Cited: 22
The ribosomal S6 kinase 2 (RSK2)–SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling
Jocelyne Lopez, Daniel A. Bonsor, Matthew J. Sale, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 6, pp. 104789-104789
Open Access | Times Cited: 8
The seventh international RASopathies symposium: Pathways to a cure—expanding knowledge, enhancing research, and therapeutic discovery
Maria I. Kontaridis, Amy E. Roberts, Lisa Schill, et al.
American Journal of Medical Genetics Part A (2022) Vol. 188, Iss. 6, pp. 1915-1927
Open Access | Times Cited: 14
LZTR1 deficiency exerts high metastatic potential by enhancing sensitivity to EMT induction and controlling KLHL12-mediated collagen secretion
Taiki Abe, Shin-ichiro Kanno, Tetsuya Niihori, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 7
A brief history of RAS and the RAS Initiative
Frank McCormick
Advances in cancer research (2022), pp. 1-27
Closed Access | Times Cited: 12
LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis
Kirsten M. Farncombe, Emily Thain, Carolina Barnett‐Tapia, et al.
BMC Medical Genomics (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 12
LZTR1Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL
Aram Ko, Mohammad Hasanain, Young Taek Oh, et al.
Cancer Discovery (2022) Vol. 13, Iss. 3, pp. 702-723
Open Access | Times Cited: 11
Minor introns impact on hematopoietic malignancies
Koutarou Nishimura, Wataru Saika, Daichi Inoue
Experimental Hematology (2024) Vol. 132, pp. 104173-104173
Closed Access | Times Cited: 2
A noncanonical GTPase signaling mechanism controls exit from mitosis in budding yeast
Xiaoxue Zhou, Shannon Y. Weng, Stephen P. Bell, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 45
Open Access | Times Cited: 2
The molecular functions of RIT1 and its contribution to human disease
Richard Van, Antonio Cuevas-Navarro, Pau Castel, et al.
Biochemical Journal (2020) Vol. 477, Iss. 15, pp. 2755-2770
Open Access | Times Cited: 17
Dysregulated minor intron splicing in cancer
Koutarou Nishimura, Hiromi Yamazaki, Weijia Zang, et al.
Cancer Science (2022) Vol. 113, Iss. 9, pp. 2934-2942
Open Access | Times Cited: 11
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells
Chitra Palanivel, Neha Chaudhary, Parthasarathy Seshacharyulu, et al.
Neoplasia (2022) Vol. 25, pp. 28-40
Open Access | Times Cited: 10
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in mice
Jasmine C. Wong, Pedro A. Pérez–Mancera, Tannie Q. Huang, et al.
JCI Insight (2020) Vol. 5, Iss. 21
Open Access | Times Cited: 15
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1
April Lo, Kristin Holmes, Shriya Kamlapurkar, et al.
Science Signaling (2021) Vol. 14, Iss. 711
Open Access | Times Cited: 13
RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma
Su Yang, Hechun Lin, Junming Yu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 5
Control of craniofacial and brain development by Cullin3-RING ubiquitin ligases: Lessons from human disease genetics
Anthony J. Asmar, David B. Beck, Achim Werner
Experimental Cell Research (2020) Vol. 396, Iss. 2, pp. 112300-112300
Open Access | Times Cited: 13

Scroll to top